Abstract:The final, formatted version of the article will be published soon. You have multiple emails registered with Frontiers: Please enter your email address: If you already have an account, please login You don't have a Frontiers account ? You can register here Introduction: Antimicrobial-resistant pathogens are an ongoing threat to human and animal health.Colistin is considered the last resort antibiotic against human infections due to multidrug-resistant Gram-negative organisms, including Acinetobacter baumanni, a priority 1 pathogen according to the WHO. Despite colistin being a last resort, transferable bacterial resistance to this drug has been reported in humans and animals, making the need to tackle colistin resistance an essential path. The large PetN transferase membrane protein PmrC is the main responsible for colistin resistance, due to its catalysed modification of lipid A of the external membrane. Despite its importance, this potential drug target was never characterised at a molecular level.Methods: Recombinant production of large membrane proteins in their native forms is a bottleneck in modern molecular biology. We recombinantly produced PmrC and biophysically characterised it in solution. We employed in silico approaches, including virtual screening and molecular modelling, to identify PmrC ligands. Binding of these ligands to PmrC was measured using Microscale thermophoresis (MST). The best ligand was tested to its ability to hamper colistin resistance in A. baumannii clinical isolates. Finally, we checked that the identified compound is not cytotoxic at the used concentrations by haemolysis assays.We successfully produced PmrC PetN transferase membrane protein in high yields and showed that PmrC is a stable - protein, with melting temperature Tm=60°C. Based on PmrC structural model, we identified a promising druggable cavity. Therefore, we used a structure based virtual screening to identify potential inhibitors. A small molecule, here denominated as s-Phen, was proved to bind PmrC with μM affinity. Microbiological assays confirmed that the s-Phen can drastically reduce colistin MIC in two A. baumannii resistant isolates and that it is not cytotoxic.Importantly, PmrC binding pocket to s-Phen is highly conserved in all homologs of PmrC, regardless of the location of genes encoding for them and of their operons.Discussion: Our study provides a molecular characterisation of PmrC and demonstrates the importance of PmrC as a drug target and the strong potential of PmrC binding molecules to act as colistin adjuvants, operating as synergistic tools to combat multi-resistant nocosomial pathogens.

PmrAB, the two-component system of Acinetobacter baumannii, controls the phosphoethanolamine modification of lipooligosaccharide in response to metal ions

Mechanistic and biophysical characterization of polymyxin resistance response regulator PmrA in Acinetobacter baumannii

PmrAB, a Two-Component Regulatory System of Pseudomonas aeruginosa That Modulates Resistance to Cationic Antimicrobial Peptides and Addition of Aminoarabinose to Lipid A

The Effect of Colistin Resistance-Associated Mutations on the Fitness of Acinetobacter Baumannii

Genetic alterations in the pmrAB two-component system and lipid A biosynthesis genes of polymyxin-resistant Acinetobacter baumannii isolates

Interactions between host epithelial cells and Acinetobacter baumannii promote the emergence of highly antibiotic resistant and highly mucoid strains

Mutation in the two-component regulator BaeSR mediates cefiderocol resistance and enhances virulence in Acinetobacter baumannii

Genomic investigation unveils colistin resistance mechanism in carbapenem-resistant Acinetobacter baumannii clinical isolates

Genetic synergy between Acinetobacter baumannii undecaprenyl phosphate biosynthesis and the Mla system impacts cell envelope and antimicrobial resistance

The Acinetobacter baumannii disinfectant resistance protein, AmvA, is a spermidine and spermine efflux pump

Acinetobacter baumannii coordinates central metabolism, plasmid dissemination, and virulence by sensing nutrient availability

Sub-minimum inhibitory concentrations of colistin and polymyxin B promote Acinetobacter baumannii biofilm formation

An Evaluation of BfmR-Regulated Antimicrobial Resistance in the Extensively Drug Resistant (XDR) Acinetobacter baumannii Strain HUMC1

Structure-based targeting of the lipid A-modifying enzyme PmrC to contrast colistin resistance in Acinetobacter baumannii

A phosphorylation signal activates genome-wide transcriptional control by BfmR, the global regulator of Acinetobacter resistance and virulence

Genetic Determinants of Acinetobacter baumannii Serum-Associated Adaptive Efflux-Mediated Antibiotic Resistance

Inactivation of AdeABC and AdeIJK efflux pumps elicits specific nonoverlapping transcriptional and phenotypic responses in Acinetobacter baumannii

Drug efflux and lipid A modification by 4-L-aminoarabinose are key mechanisms of polymyxin B resistance in the sepsis pathogen Enterobacter bugandensis

Acinetobacter baumannii Antibiotic Resistance Mechanisms

Abrp, A New Gene, Confers Reduced Susceptibility to Tetracycline, Glycylcine, Chloramphenicol and Fosfomycin Classes in Acinetobacter Baumannii

Acinetobacter baumannii quorum-sensing signalling molecule induces the expression of drug-resistance genes.